SCHEMBL5607889

SCHEMBL5607889

COC(=Cc1ccc(OCc2ccccc2)cc1)C(=O)O.[BaH2]

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H4 Q96RI1 1/20 0.59
GSK3B P49841 3/20 0.58
BACE1 P56817 3/20 0.58
MAOB P27338 2/20 0.56
NPC1 O15118 5/20 0.55
RAB9A P51151 4/20 0.55
SMN1; SMN2 Q16637 3/20 0.55
KDM4E B2RXH2 4/20 0.54
MAPT P10636 2/20 0.54
GAA P10253 1/20 0.54
MEN1 O00255 2/20 0.54
KMT2A Q03164 2/20 0.54
TDP1 Q9NUW8 1/20 0.54
CYP1A2 P05177 1/20 0.52
CYP2C19 P33261 1/20 0.52
ALDH1A1 P00352 2/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
NR4A1 P22736 1/20 0.51
NR4A2 P43354 1/20 0.51
NR4A3 Q92570 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5606805 0.99 NR1H4 (0.60) NR1H4GSK3BBACE1MAOBNPC1
SCHEMBL5606809 0.99 NR1H4 (0.60) NR1H4GSK3BBACE1MAOBNPC1
Rubidium SCHEMBL5606895 0.97 NR1H4 (0.59) NR1H4GSK3BBACE1MAOBNPC1
Ammonia Solution, Strong SCHEMBL5606804 0.97 NR1H4 (0.59) NR1H4GSK3BBACE1MAOBNPC1
SCHEMBL5608232 0.97 NR1H4 (0.59) NR1H4GSK3BBACE1MAOBNPC1
SCHEMBL5607708 0.97 NR1H4 (0.59) NR1H4GSK3BBACE1MAOBNPC1
SCHEMBL5606697 0.97 NR1H4 (0.59) NR1H4GSK3BBACE1MAOBNPC1
Ammonia Solution, Strong SCHEMBL5606807 0.97 NR1H4 (0.59) NR1H4GSK3BBACE1MAOBNPC1
Methylamine SCHEMBL5606883 0.96 NR1H4 (0.57) NR1H4GSK3BBACE1MAOBNPC1
Methylamine SCHEMBL5606880 0.96 NR1H4 (0.57) NR1H4GSK3BBACE1MAOBNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070142472-A1 Process for producing optically active 3-(4-hydroxyphenyl)proprionic acids TAKASAGO INTERNATIONAL CORPORATION (JP) 2007-06-21 US disclosed
EP-1687250-A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE 3-(4-HYDROXYPHENYL)PROPIONIC ACIDS Takasago International Corporation (JP) 2006-08-09 EP disclosed
WO-2005051882-A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE 3-(4-HYDROXYPHENYL)PROPIONIC ACIDS TAKASAGO INTERNATIONAL CORPORATION (JP) 2005-06-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070142472-A1 Process for producing optically active 3-(4-hydroxyphenyl)proprionic acids ALDH1A2, ALDH1A3, GRHPR NR1H4 220/4885GSK3B 2848/4885BACE1 1867/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.